AHU-377 (heMicalciuM salt)
Synonym(s):(2R,4S)-4-[(3-Carboxy-1-oxopropyl)amino]-4-[(p-phenylphenyl)methyl]-2-methylbutanoic acid ethyl ester;4-[[(2S,4R)-5-Ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoic acid calcium salt;4-{[(2S,4R)-1-(4-Biphenylyl)-5-ethoxy-4-methyl-5-oxo-2-pentanyl]amino}-4-oxobutanoic acid; (2R,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester;AHU377 calcium salt;AHU-377 calcium salt
- CAS NO.:1369773-39-6
- Empirical Formula: C48H56CaN2O10
- Molecular Weight: 861.04364
- MDL number: MFCD28137893
- EINECS: 935-847-3
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-19 23:02:33
What is AHU-377 (heMicalciuM salt)?
The Uses of AHU-377 (heMicalciuM salt)
Sacubitril is an antihypertensive drug used in combination with valsartan. The combination drug, valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name, Entresto, is a treatment for heart failure.
Biochem/physiol Actions
Sacubitril (AHU377) is a prodrug inhibitor of the membrane metallo-endopeptidase neprilysin. Sacubitril forms half of the heart failure combination drug LCZ696, along with the angiotensin-receptor blocker Valsartan. Sacubitril (AHU377) is cojnverted by esterases into the active inhibitor LBQ657, which prevents neprilysin′s degradation of atrial and brain natriuretic peptide, two blood pressure lowering peptides. The AHU377 valsartan combination drug LCZ696 showed a reduction in the risk of cardiovascular death of 20% compared to the standard ACE inhibitor enalapril, and also a 21% drop in the risk of hospitalization.
storage
Store at -20°C
Properties of AHU-377 (heMicalciuM salt)
Melting point: | >140°C (dec.) |
Density | 1.24g/cm3 at 20℃ |
vapor pressure | 0.001Pa at 20℃ |
storage temp. | -20°C |
solubility | DMSO (Slightly, Heated), Methanol (Slightly) |
form | powder |
color | white to beige |
Safety information for AHU-377 (heMicalciuM salt)
Signal word | Danger |
Pictogram(s) |
Skull and Crossbones Acute Toxicity GHS06 Environment GHS09 |
GHS Hazard Statements |
H301:Acute toxicity,oral H400:Hazardous to the aquatic environment, acute hazard |
Precautionary Statement Codes |
P273:Avoid release to the environment. |
Computed Descriptors for AHU-377 (heMicalciuM salt)
Abamectin manufacturer
Svak Life Sciences
Venkatasai Life Sciences
Orgamine Chemicals(I) Pvt Ltd
New Products
4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
1369773-39-6 98%View Details
1369773-39-6 -
Sacubitril calcium salt 98%View Details
1369773-39-6 -
Ahu-377 hemicalcium salt 95% CAS 1369773-39-6View Details
1369773-39-6 -
1369773-39-6 99%View Details
1369773-39-6 -
Sacubitril calcium salt 98%View Details
1369773-39-6 -
1369773-39-6 Sacubitril calcium salt 99%View Details
1369773-39-6 -
Sacubitril hemicalcium salt 98% (HPLC) CAS 1369773-39-6View Details
1369773-39-6 -
Sacubitril calcium salt CAS 1369773-39-6View Details
1369773-39-6